Literature DB >> 22296996

Does post-mastectomy radiotherapy represent a contraindication to skin-sparing mastectomy and immediate reconstruction: an update.

K Lambert1, K Mokbel.   

Abstract

The use of skin-sparing mastectomy (SSM) to facilitate breast reconstruction is increasing due to a wide acceptance of improved cosmetic outcomes and evidence of equivalence in oncologic outcomes. The rates of patients undergoing mastectomy for whom post-mastectomy radiotherapy (PMRT) will be recommended is increasing as evidence of decreased loco-regional recurrence and increased survival mounts. PMRT may adversely effect complication rates and cosmetic outcomes for patients undergoing immediate breast reconstruction and PMRT--although the evidence for this is methodologically flawed. This article summarises the above evidence and highlights a reconstructive algorithm that may be used to mitigate the possible deleterious effects of PMRT on results.
Copyright © 2012. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22296996     DOI: 10.1016/j.suronc.2011.12.007

Source DB:  PubMed          Journal:  Surg Oncol        ISSN: 0960-7404            Impact factor:   3.279


  4 in total

1.  Accuracy of a multidisciplinary team-led discussion in predicting postmastectomy radiotherapy.

Authors:  M Wilson; M Dordea; A Light; M P Serra; S R Aspinall
Journal:  Ann R Coll Surg Engl       Date:  2015-04       Impact factor: 1.891

2.  Factors influencing the decision to pursue immediate breast reconstruction after mastectomy for breast cancer.

Authors:  Mariska Weenk; Philipp Wunschel; Erwin Heine; Luc J Strobbe
Journal:  Gland Surg       Date:  2017-02

3.  Evolving role of skin sparing mastectomy.

Authors:  Abdul Kasem; Kefah Mokbel
Journal:  World J Clin Oncol       Date:  2014-05-10

Review 4.  Adipose-Derived Stem Cells in Novel Approaches to Breast Reconstruction: Their Suitability for Tissue Engineering and Oncological Safety.

Authors:  Niamh O'Halloran; Donald Courtney; Michael J Kerin; Aoife J Lowery
Journal:  Breast Cancer (Auckl)       Date:  2017-08-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.